CN101020028B

CN101020028B - Chinese medicine for treating cardiac and cerebral vascular diseases

Info

Publication number: CN101020028B
Application number: CN200610151025A
Authority: CN
Inventors: 刘志民; 刘光辉; 刘金辉; 刘新颖
Original assignee: 刘光辉
Priority date: 2006-11-11
Filing date: 2006-11-11
Publication date: 2010-05-19
Anticipated expiration: 2026-11-11
Also published as: CN101020028A

Abstract

The Chinese medicine for treating cardiac and cerebral vascular diseases is prepared with American ginseng, astragalus root, angelica, leatherleaf milletia, saffron and other 23 kinds of Chinese medicinal materials. It has the functions of dilating blood vessel, antagonizing coagulation, eliminating thrombus, improving blood circulation, etc. It is used in treating coronary heart disease, angina,myocardial ischemia and other cardiac and cerebral vascular diseases. It has the advantages of short treating period, fast acting, no resistance, no toxic side effect and high effective rate.

Description

A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease

Technical field

The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease.

Background technology

Cardiovascular and cerebrovascular disease is meant cardio cerebrovascular affection and then causes the disease of heart and brain tissues blood supply disorder.Heart disease mainly shows as coronary heart disease and angina pectoris.Cerebrovascular mainly shows as hemorrhagic apoplexy and ischemic cerebrovascular.And cardiovascular and cerebrovascular disease such as cerebral arteriosclerosis, coronary heart disease, angina pectoris, cerebral thrombosis, cerebral infarction, cerebral hemorrhage has become healthy frequently-occurring disease of a kind of serious harm middle-aged and elderly people and common property disease.Therefore the prevention of cardiovascular and cerebrovascular disease and treatment have become the important topic of society and medical circle concern.Treat the compound medicines function singleness of cardiovascular and cerebrovascular disease at present, slow curative effect.

Summary of the invention

The object of the present invention is to provide a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, short treating period, instant effect, no Drug resistance and toxic and side effects.

Medicine of the present invention is monarch with QI replenishing and blood harmonizing benefit blood medicine, and choosing is with Radix Panacis Quinquefolii, the Radix Astragali, Radix Angelicae Sinensis, Caulis Spatholobi; With blood circulation promoting and blood stasis dispelling, Pimobendane is minister, selects Radix Notoginseng, Stigma Croci, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Semen Persicae, Ramulus Cinnamomi for use; Assistant with anticoagulant thromboembolism preventing thrombolytic, activate self streptokinase medicine, select Hirudo, Pheretima, Agkistrodon, Scorpio, Scolopendra for use; Make with blood fat reducing, fall blood thickness, cholesterol reducing, hypotensor, choosing is with Fructus Crataegi, Ramulus Uncariae Cum Uncis, Rhizoma Gastrodiae, Radix Curcumae, the Radix Aucklandiae, Rhizoma Alismatis, Flos Sophorae, Radix Sophorae Flavescentis, Radix Puerariae, Semen Cassiae; Be aided with drugs of causing resuscitation by administering aromatic drugs again, priming penetrates blood brain barrier, and through sick medicine is selected Moschus and Borneolum Syntheticum for use.

Use Chinese medicine of the present invention, blood vessel dilating, activates self streptokinase, blood fat reducing, falls blood thickness, cholesterol reducing, blood pressure lowering, mediation blood vessels, improves blood circulation anticoagulant thromboembolism preventing, thrombolysis and thrombus diminishing, change bolt row bolt.Cure mainly coronary heart disease, angina pectoris, myocardial ischemia, myocardial infarction, arrhythmia, atrial fibrillation, cardiovascular disease such as cardiopalmus heart beating, chest pain are weak, sensation of oppression over the chest with shortness of breath, rich, vexed, insomnia early, night sweat and paroxysmal pareordia breastbone pain.Apoplexy, cerebral thrombosis, cerebral embolism, cerebral infarction, brain atrophy, cerebral blood supply insufficiency, cerebral hemorrhage are lost cerebrovascular disease such as disease, hemiplegia.Diseases such as hyperlipidemia, hypertension, high blood viscosity are thick, hypercholesterolemia, arteriosclerosis.

Chinese medicine of the present invention is made by the crude drug of following weight ratio: Radix Panacis Quinquefolii 5-8%, Radix Astragali 10-16%, Radix Angelicae Sinensis 3-5%, Caulis Spatholobi 3-5%, Stigma Croci 1-3%, Radix Notoginseng 3-5%, Radix Salviae Miltiorrhizae 4-6%, Rhizoma Chuanxiong 6-12%, Radix Paeoniae Rubra 3-6%, Semen Persicae 3-6%, Ramulus Cinnamomi 3-6%, Hirudo 2-4%, Pheretima 4-6%, Agkistrodon 3-6%, Scorpio 1.5-3%, Scolopendra 1-3%, Fructus Crataegi 3-6%, Ramulus Uncariae Cum Uncis 3-6%, Rhizoma Gastrodiae 2-3%, Radix Curcumae 3-6%, Radix Aucklandiae 1.5-3%, Rhizoma Alismatis 2-3%, Flos Sophorae 3-5%, Radix Sophorae Flavescentis 3-5%, Radix Puerariae 3-5%, Semen Cassiae 3-5%, Moschus 0.1-0.15%, Borneolum Syntheticum 0.8-1.5%.

Preparation method: pulverization make capsule or routinely pharmaceutical methods make tablet or other dosage form.

The specific embodiment

Preferably: Radix Panacis Quinquefolii 6%, the Radix Astragali 12%, Radix Angelicae Sinensis 3.6%, Caulis Spatholobi 3.6%, Stigma Croci 1.2%, Radix Notoginseng 3.6%, Radix Salviae Miltiorrhizae 5%, Rhizoma Chuanxiong 7.2%, Radix Paeoniae Rubra 3.6%, Semen Persicae 3.6%, Ramulus Cinnamomi 3.6%, Hirudo 2.4%, Pheretima 5%, Agkistrodon 3.6%, Scorpio 1.8%, Scolopendra 1.2%, Fructus Crataegi 3.6%, Ramulus Uncariae Cum Uncis 3.6%, Rhizoma Gastrodiae 2.5%, Radix Curcumae 3.6%, the Radix Aucklandiae 1.8%, Rhizoma Alismatis 2.5%, Flos Sophorae 3.6%, Radix Sophorae Flavescentis 3.6%, Radix Puerariae 3.6%, Semen Cassiae 3.6%, Moschus 0.1%, Borneolum Syntheticum 0.9%.Pulverization is made capsule or tablet.Take 10g at every turn, obey every day 3 times.

Below by clinical observation test, further set forth the beneficial effect of Chinese medicine of the present invention.

The present invention treats the 1000 routine hearts, cerebrovascular patient altogether, clinical symptoms: apoplectic hemiplegia, aphasia, facial hemiparalysis, hemiplegia, with after together veiny recover gradually, month person of medication generally recovers self care ability fully, walking is normal, normal, facial hemiparalysis is no more than and 1 week recovered normal in a minute, blood pressure is kept normally, does not stay sequela.Cure rate reaches 99%, effect stability.Cure rate reaches 98%, and total effective rate reaches 100%.

1, the clinical experiment of treatment by Chinese herbs 100 routine coronary heart disease of the present invention and patient with angina pectoris report:

Clinical symptoms: uncomfortable in chest, feel suffocated, angina pectoris.Through taking Chinese medicine of the present invention, coronary heart disease causes in 12 hours has palpitation, breathe hard, symptom such as uncomfortable in chest can be alleviated rapidly, and angina pectoris symptom has clear improvement, and generally takes 3-10 days symptoms obviously to alleviate, and blood pressure stabilization is taken 1-2 the course of treatment, and symptom disappears substantially.

2, treatment by Chinese herbs cerebral thrombus patient 100 examples of the present invention, sign: consciousness, visual disorder; Paresis or hemiplegia, side sensory disturbance partially; Speech disorder; Movement disorder.Take Chinese medicine of the present invention after 30 days spirit be clearly better, trick is strong, the hemiplegic patient can walk with descending, it is normal that language function recovers, take 2-3 the course of treatment after, limbs and language function recover fully, can take a walk in a minute.Cure rate reaches 98%, and total effective rate reaches 100%.

3, treatment by Chinese herbs cerebral arteriosclerosis 100 examples of the present invention, clinical manifestation: comprise neurasthenia symptom, as dizziness, headache, hypomnesis, ability to work decline and autonomic nervous dysfunction etc.Dementia arteriosclerotica mainly shows as spirit, affective disorder.Patient's symptom and sign disappears or the person's of having clear improvement 98 examples, and effectively, patient's symptom obviously alleviates, and sign is improved or clinical symptoms body disappearance person 2 examples, invalid 0 example.Cure rate reaches 98%, and total effective rate reaches 100%.

Claims

1. Chinese medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that being made by the crude drug of following weight ratio:

Radix Panacis Quinquefolii 5-8%, Radix Astragali 10-16%, Radix Angelicae Sinensis 3-5%, Caulis Spatholobi 3-5%, Stigma Croci 1-3%, Radix Notoginseng 3-5%, Radix Salviae Miltiorrhizae 4-6%, Rhizoma Chuanxiong 6-12%, Radix Paeoniae Rubra 3-6%, Semen Persicae 3-6%, Ramulus Cinnamomi 3-6%, Hirudo 2-4%, Pheretima 4-6%, Agkistrodon 3-6%, Scorpio 1.5-3%, Scolopendra 1-3%, Fructus Crataegi 3-6%, Ramulus Uncariae Cum Uncis 3-6%, Rhizoma Gastrodiae 2-3%, Radix Curcumae 3-6%, Radix Aucklandiae 1.5-3%, Rhizoma Alismatis 2-3%, Flos Sophorae 3-5%, Radix Sophorae Flavescentis 3-5%, Radix Puerariae 3-5%, Semen Cassiae 3-5%, Moschus 0.1-0.15%, Borneolum Syntheticum 0.8-1.5%.

2. a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1 is characterized in that being made by the crude drug of following weight ratio: Radix Panacis Quinquefolii 6%, the Radix Astragali 12%, Radix Angelicae Sinensis 3.6%, Caulis Spatholobi 3.6%, Stigma Croci 1.2%, Radix Notoginseng 3.6%, Radix Salviae Miltiorrhizae 5%, Rhizoma Chuanxiong 7.2%, Radix Paeoniae Rubra 3.6%, Semen Persicae 3.6%, Ramulus Cinnamomi 3.6%, Hirudo 2.4%, Pheretima 5%, Agkistrodon 3.6%, Scorpio 1.8%, Scolopendra 1.2%, Fructus Crataegi 3.6%, Ramulus Uncariae Cum Uncis 3.6%, Rhizoma Gastrodiae 2.5%, Radix Curcumae 3.6%, the Radix Aucklandiae 1.8%, Rhizoma Alismatis 2.5%, Flos Sophorae 3.6%, Radix Sophorae Flavescentis 3.6%, Radix Puerariae 3.6%, Semen Cassiae 3.6%, Moschus 0.1%, Borneolum Syntheticum 0.9%.